Remus Pharmaceuticals Ltd logo

Remus Pharmaceuticals Ltd (REMUS)

₹4436.650.97%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Technicals
News and Events

Overview of Remus Pharmaceuticals Ltd

Key events for Remus Pharmaceuticals Ltd

  • Remus Pharma Among Top Gainers in SME IPO Market - 15 Sep, 2023

    Remus Pharmaceuticals Ltd's stock has gained significant traction in the SME IPO market, making it one of the top gainers.

Remus Pharmaceuticals Ltd Performance

  • ₹4350
    ₹4461
    ₹4436.65
    downward going graph

    1.95%

    Downside

    Day's Volatility:2.50%

    Upside

    0.55%

    downward going graph
  • ₹1711.25
    ₹4905
    ₹4436.65
    downward going graph

    61.43%

    Downside

    52 Weeks Volatility:71.99%

    Upside

    10.56%

    downward going graph
1 Month Return-3.96 %
3 Month Return36.45 %
1 Year Return144.55 %
Previous Close₹4,394.00
Open₹4,410.00
Volume4,200.00
Market Cap₹647.24Cr

Remus Pharmaceuticals Ltd Company Information

Remus Pharmaceuticals Limited, originally incorporated as Remus Pharmaceuticals Private Limited in 2015, is engaged in the marketing and distribution of finished formulations of pharmaceutical drugs. It deals in various drug forms such as capsules, creams, gel, injection, tablets, etc. and supplies therapeutic drugs like ACE inhibitors, anaesthetics, antihistamines, anticancer, etc. Remus Pharmaceuticals' core business includes manufacturing approved finished formulations through loan licence and contract manufacturing, trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers. It has a product portfolio of 429 products, 58 domestic distributors and 139 international distributors. Currently, the company is proposing an initial public offering of up to 388000 Equity Shares through its Fresh Issue.

Share Price: ₹4436.65 per share as on 21 Sep, 2023 04:01 PM
Market Capitalisation: ₹647.24Cr as of today
Listing date: 29 May, 2023
OrganisationRemus Pharmaceuticals Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Fundamentals of Remus Pharmaceuticals Ltd

Insights on Remus Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise
    img

    In the last 6 months, REMUS stock has moved up by 144.6%

  • imgPOSITIVE IMPACT

    FII Holding Up
    img

    Foreign Institutions have increased holdings from 0.00% to 2.55% in May 2023 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up
    img

    Retail Investor have increased holdings from 7.18% to 26.03% in May 2023 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down
    img

    Promoters have decreased holdings from 92.82% to 68.37% in May 2023 quarter

Remus Pharmaceuticals Ltd Shareholding Pattern

InvestorsHoldings %Prev. 2 periods3M change
Promoter Holdings
68.37%
-26.34
Foreign Institutions
2.55%
0.00
Mutual Funds
0%
0.00
Retail Investors
26.03%
262.62
Others
3.05%
0.00

Technicals of Remus Pharmaceuticals Ltd

News & Events of Remus Pharmaceuticals Ltd

Frequently Asked Questions

Remus Pharmaceuticals Ltd (REMUS) share price today is ₹4436.65

  • Today’s highest price of Remus Pharmaceuticals Ltd is ₹4461.
  • Today’s lowest price of Remus Pharmaceuticals Ltd is ₹4350.

Today’s traded volume of Remus Pharmaceuticals Ltd(REMUS) is 4,200.00.

Today’s market capitalisation of Remus Pharmaceuticals Ltd(REMUS) is ₹647.24Cr.

Remus Pharmaceuticals Ltd(REMUSPrice
52 Week High
₹4905
52 Week Low
₹1711.25

Remus Pharmaceuticals Ltd(REMUS) share price is ₹4436.65. It is down -9.55% from its 52 Week High price of ₹4905

Remus Pharmaceuticals Ltd(REMUS) share price is ₹4436.65. It is up 159.26% from its 52 Week Low price of ₹1711.25

Remus Pharmaceuticals Ltd(REMUSReturns
1 Day Returns
42.65%
1 Month Returns
-3.96%
3 Month Returns
36.45%
1 Year Returns
144.55%